Zelluna Immunotherapy
Biotechnology ResearchView the employees at
Zelluna Immunotherapy-
Maja Sandve Associate scientist
-
Oslo, Oslo, Norway
-
Rising Star
Frida H. Haugen Master student at Center for Molecular Medicine Norway (NCMM)-
Oslo, Oslo, Norway
-
Rising Star
-
Hamburg, Hamburg, Germany
-
Rising Star
Michelle Sætersmoen Platform Development Scientist at Zelluna Immunotherapy-
Oslo og omegn
-
Rising Star
Overview
Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable. For more info please visit www.zelluna.com
-